Orteq signs French deal for synthetic scaffold
This article was originally published in Clinica
Executive Summary
UK orthopaedic firm Orteq Bioengineering has signed a distribution deal with FH Orthopaedics, in a bid to increase sales of its Actifit synthetic scaffold for meniscal injury in France. The deal will allow FH (Heimsbrunn, France) to increase the coverage of Actifit, which, a spokesperson told Clinica, was only sold by Orteq in the country at a “low level” previously. Financial terms of the agreement were not disclosed. According to London-based Orteq, Actifit provides a structure for growth of new tissue, in places were damaged meniscal tissue has been surgically removed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals